$CEVA Cashflow Statement | Understand Stock

$CEVA

$31.35 +$1.94 (6.6%) Live

$CEVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss:
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation
Amortization of intangible assets
Impairment of intangible assets
Equity-based compensation
Realized gain, net on sale of available-for-sale marketable securities
Amortization of discounts on available-for-sale marketable securities
Unrealized foreign exchange (gain) loss, net
Gain on sale of Intrinsix
Remeasurement of marketable equity securities
Changes in operating assets and liabilities:
Trade receivables, net
Prepaid expenses and other assets
Operating lease right-of-use assets
Accrued interest on bank deposits
Deferred taxes, net
Trade payables
Deferred revenues
Accrued expenses and other payables
Accrued payroll and related benefits
Operating lease liability
Income taxes payable
Accrued severance pay, net
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Business combination
Asset acquisition
Purchase of property and equipment
Purchase of intangible assets
Proceeds from the sale of Intrinsix, net
Investment in bank deposits
Proceeds from bank deposits
Investment in available-for-sale marketable securities
Proceeds from maturity of available-for-sale marketable securities
Proceeds from sale of available-for-sale marketable securities
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Purchase of treasury stock
Payment of contingent consideration liability
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of stock-based awards
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Supplemental information of cash-flows activities:
Income and withholding taxes
Non-cash transactions:
Transaction costs related to the Intrinsix but unpaid at the end of the year
Property and equipment purchases incurred but unpaid at the end of the year
Right-of-use assets obtained in the exchange for operating lease liabilities
Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow:
Cash and cash equivalents in the Consolidated Balance Sheets
Cash and cash equivalents included in assets of discontinued operation

Comments